Recent studies suggest a potential link between hormone therapy and Alzheimer's disease and dementia. Hormone therapy, particularly estrogen, has been explored due to its role in brain health and cognitive function. Estrogen is believed to have neuroprotective effects, potentially reducing the risk of developing Alzheimer's disease by maintaining neuronal health and synaptic function. However, the relationship is complex, as hormone therapy's benefits may depend on various factors such as the timing of treatment initiation and duration. Some studies indicate that starting hormone therapy around the onset of menopause might be more beneficial for cognitive outcomes than starting later in life. Nonetheless, more research is needed to fully understand the effects of hormone therapy on Alzheimer's disease and dementia, including its long-term risks and benefits.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia